Releaf
From Wikipedia, the free encyclopedia
 | |
Company type | Private |
|---|---|
| Industry | Medical cannabis |
| Founded | 2022 |
| Founders | Mason Soiza |
| Headquarters | , United Kingdom |
Area served | United Kingdom Germany |
Key people | Tim Kirby (CEO) |
| Products | Releaf Patient Platform Releaf Medical Cannabis Card Releaf Protect |
| Services | Medical cannabis consultations Cannabis-based prescription medicines (CBPMs) Patient legal support |
| Website | releaf releaf |
Releaf is a British medical cannabis clinic, licensed to prescribe and dispense cannabis-based prescription medicines (CBPMs) in the United Kingdom. It is based in London, England.
Releaf Dispensary was founded in 2022 by Mason Soiza. In March 2023, Releaf raised £1.5 million in a funding round ahead of its commercial launch.[1] Also, in 2023, Releaf joined the UK's Cannabis Industry Council as a clinic member.[2]
In June 2024, Releaf formed a joint initiative with UK cultivator Glass Pharms to supply domestically grown medical cannabis flowers to patients.[3][4] Chloe Durrington became the first patient in the UK to be prescribed by Releaf.[3]
In September 2025, Releaf acquired the domain name Releaf.com for £110,000.[5] In October 2025, Releaf expanded its operations to Germany following 2024 regulatory reforms were passed.[6]
In January 2026, Releaf launched Releaf Protect, a legal guidance helpline for UK medical cannabis patients, in a joint initiative with Irwin Mitchell.[7] As of March 2026, Releaf had over 25,000 patients and over £38m of revenue.[8]
